W. Woloszczuk - Concepedia

Author

W. Woloszczuk

University of Vienna

Also Known As

W WOLOSZCZUK, W Woloszczuk, W. WOLOSZCZUK, W. Woloszczuk, WOLFGANG WOLOSZCZUK, Wolfgang WOLOSZCZUK, Wolfgang Woloszczuk

207

Publications

5.2K

Citations

H-Index

126

Concepts

All Affiliations

University of Vienna Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA Ludwig Boltzmann Institute for Digital Health and Prevention Ludwig Boltzmann Institute for Age Research Medical University of Vienna

About

W. Woloszczuk is an author at University of Vienna specializing in medicine, physiology, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	53	2.6K
2	Health Sciences	12	12	705
3	Allergy	4	4	184
4	Public Health	2	2	53
5	Natural Sciences	1	1	16

W. Woloszczuk

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin Kurt Redlich, Silvia Hayer, Andrea Maier, Arthritis & Rheumatism	2002	286
Plasma Ghrelin Concentrations Are Not Regulated by Glucose or Insulin Georg Schaller, Johannes Pleiner, W. Woloszczuk, Diabetes	2003	205
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans E Hartter, Thomas Svoboda, Bernhard Ludvik, Diabetologia BiochemistryPlasma LevelsInsulin ManagementDiabetesPhysiology	1991	193
Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy Thomas Stefenelli, Harald Mayr, Jutta Bergler‐Klein, The American Journal of Medicine UrologyParathyroid HormoneParathyroid DiseaseEndocrine SurgerySurgery	1993	187
Serum levels of osteoprotegerin increase with age in a healthy adult population Stefan Kudlacek, Barbara Schneider, W. Woloszczuk, Bone Healthy Adult PopulationBone DiseaseBone HealthAgingLongevity	2003	185
Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications Peter Pietschmann, Guntram Schernthaner, W. Woloszczuk Diabetologia Metabolic SyndromeDiabetesPhysiologyOsteoarthritisSerum Osteocalcin Levels	1988	126
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha Heinz Gisslinger, Bettina Gilly, W. Woloszczuk, Clinical & Experimental Immunology	1992	125
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide Athanasios D. Anastasilakis, Cornelia Bratengeier, W. Woloszczuk, Osteoporosis International Serum Sclerostin LevelsSclerostinBone HealthSix-month EffectMenopause	2011	123
Bone disease in vitamin D-deficient patients with Crohn's disease Harald Vogelsang, Péter Ferenci, W. Woloszczuk, Digestive Diseases and Sciences Bone DiseaseBone HealthOsteoarthritisMedicineOsteoporosis	1989	116
The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism Peter Pietschmann, Eva Gollob, Susanne Brosch, Experimental Gerontology InflammationCytokine ProductionBone HealthAutoimmune DiseasePhysiology	2003	110

Page 1